Sabby Volatility Fund Discloses 97,305 Share Stake in Arcadia Bio
Ticker: RKDA · Form: SC 13G · Filed: Jan 3, 2024 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | SC 13G |
| Filed Date | Jan 3, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, SC-13G, shareholder-disclosure
TL;DR
**Sabby Volatility Fund just revealed a 97,305 share stake in Arcadia Biosciences.**
AI Summary
Sabby Volatility Warrant Master Fund, Ltd., a Cayman Islands-based entity, reported beneficial ownership of 97,305 shares of Arcadia Biosciences, Inc. common stock as of December 31, 2023. This filing, an SC 13G, indicates that Sabby Volatility Warrant Master Fund, Ltd. holds shared voting and dispositive power over these shares. This matters to investors because it reveals a significant institutional holder's position in Arcadia Biosciences, Inc., potentially signaling confidence or a strategic investment in the company's future.
Why It Matters
This filing shows a notable institutional investor, Sabby Volatility Warrant Master Fund, Ltd., has taken a position in Arcadia Biosciences, Inc., which can influence market perception and liquidity for the stock.
Risk Assessment
Risk Level: low — This is a routine disclosure of an institutional holding and does not inherently signal high risk, but rather transparency.
Analyst Insight
Investors should note this institutional ownership as a data point, but further research into Sabby Volatility Warrant Master Fund, Ltd.'s investment strategy and Arcadia Biosciences, Inc.'s fundamentals is needed before making investment decisions.
Key Numbers
- 97,305 — Shares Beneficially Owned (The total number of Arcadia Biosciences, Inc. common stock shares held by Sabby Volatility Warrant Master Fund, Ltd.)
- December 31, 2023 — Date of Event (The date on which the beneficial ownership was determined for this filing.)
- 039014204 — CUSIP Number (Unique identification number for Arcadia Biosciences, Inc. common stock.)
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — the subject company whose shares are being reported
- Sabby Volatility Warrant Master Fund, Ltd. (company) — the reporting person beneficially owning shares
- Sabby Management, LLC (company) — the entity that filed the SC 13G on behalf of the fund
- Cayman Islands (company) — place of organization for Sabby Volatility Warrant Master Fund, Ltd.
Forward-Looking Statements
- Sabby Volatility Warrant Master Fund, Ltd. will maintain its stake in Arcadia Biosciences, Inc. for the near term. (Sabby Volatility Warrant Master Fund, Ltd.) — medium confidence, target: Q2 2024
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is Sabby Volatility Warrant Master Fund, Ltd., as stated in Item 1 of the filing.
What is the total number of shares beneficially owned by the reporting person?
Sabby Volatility Warrant Master Fund, Ltd. beneficially owns 97,305 shares of Arcadia Biosciences, Inc. common stock, as indicated in Row 9 of the cover page.
What type of voting and dispositive power does the reporting person have over these shares?
The reporting person has shared voting power over 97,305 shares (Row 6) and shared dispositive power over 97,305 shares (Row 8).
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the cover page.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(c), as indicated by the checked box on the cover page.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 3, 2024 regarding Arcadia Biosciences, Inc. (RKDA).